Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Obsessive-compulsive Disorder (OCD) article more useful, or one of our other health articles.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Obsessive-compulsive disorder (OCD) may be characterised by the presence of obsessions or compulsions but commonly both.
- Obsessions are unwanted intrusive thoughts, images or urges that repeatedly enter the person's mind.
- Compulsions are repetitive behaviours or mental acts that the person feels driven to perform. They can be overt (observable by others) - eg, checking a door is locked; or they can be covert - eg, a mental act that cannot be observed, such as repeating a certain phrase in one's mind.
Studies vary but the figure for prevalence ranges from 0.8-3% in adults and 0.25-2% in children and adolescents. Onset is most commonly in late adolescence and early twenties but can occur at any age.
Aetiology seems to be multifactorial, involving several possible components:
- Genetic. Twin studies suggest a genetic predisposition.
- Developmental factors. Abuse or neglect, social isolation, teasing or bullying may predispose.
- Psychological factors. Personality characteristics maintain OCD.
- Stressors/triggers. A common stressor is pregnancy or the postnatal period.
- Neurological conditions. Occasionally OCD is a presenting sign of a neurological condition such as a tumour or frontotemporal dementia, or the result of trauma to the brain.
The International Classification of Diseases 10th Edition (ICD-10) definition of OCD applies the following criteria:
- Either obsessions or compulsions (or both) must be present on most days for a period of at least two weeks.
- They are acknowledged as originating in the mind of the patient and are not imposed by outside persons or influences.
- They are repetitive and unpleasant and at least one obsession or compulsion must
be present that is acknowledged as excessive or unreasonable.
- The subject tries to resist them (but if very long-standing, resistance to some obsessions or compulsions may be minimal). At least one obsession or compulsion must be present which is unsuccessfully resisted.
- Carrying out the obsessive thought or compulsive act is not in itself pleasurable.
- The obsessions or compulsions cause distress or interfere with the subject's social or individual functioning, usually by wasting time.
There are frequently comorbid conditions, namely one of the following:
- Social and other phobias.
- Alcohol misuse.
- General anxiety disorder.
- Body dysmorphic disorder (BDD).
- Eating disorders.
- Bipolar disorder.
- Tourette's syndrome.
- Autistic spectrum disorder.
People with OCD often do not volunteer their symptoms spontaneously and it is likely that there is under-diagnosis of this condition. Assessment should include the following elements:
- Identify cases - for patients at risk of OCD (depression, anxiety, BDD, substance misuse or eating disorder), ask the following questions:
- Do you wash or clean a lot?
- Do you check things a lot?
- Is there any thought that keeps bothering you that you would like to get rid of but cannot?
- Do your daily activities take a long time to finish?
- Are you concerned about putting things in a special order or are you very upset by mess?
- Do these problems trouble you?
- Assess severity, ie how much it is affecting the patient's ability to function in everyday life. National Institute for Health and Care Excellence (NICE) guidance bases management guidelines on degree of severity but does not specify how this should be assessed. Essentially assess the effect the condition has on quality of life, school or work, relationships and social life. Rating scales such as the Yale-Brown Obsessive Compulsive Scale may be used.
- Assess the risk of self-harm or suicide and the presence of comorbidity such as depression.
- Arrange referral to appropriate secondary care provision.
- Ensure continuity of care to avoid multiple assessments, gaps in service and a smooth transition from child to adult services (many patients have lifelong symptoms).
- Promote understanding - make patients/families aware of the involuntary nature of symptoms. Consider patient information leaflets, contact numbers of self-help groups, etc.
- Consider the bigger picture - cultural, social, emotional and mental health needs.
- If the patient is a parent, consider child protection issues.
NICE recommends referral to a specialist multidisciplinary team offering age-appropriate care.
Mild functional impairment
People with mild functional impairment can be successfully managed with low-intensity psychological treatment. A psychological intervention should be recommended as first-line therapy. This is accessed by referral or self-referral to the Improving Access to Psychological Therapies (IAPT) scheme. Options for therapy include:
- Individual cognitive behavioural therapy (CBT) plus exposure and response prevention (ERP).
- Individual CBT and ERP by telephone or internet.
- Group CBT.
- A couples-based course, which has been developed for patients in long-term relationships.
If the person has been unable to engage in low-intensity CBT (including ERP) or the response is inadequate then offer the choice of a selective serotonin reuptake inhibitor (SSRI) or higher-intensity psychological therapy. (Higher intensity essentially refers to the level of hours of input of therapy.)
Moderate functional impairment
Those with moderate functional impairment should be offered a choice between high-intensity CBT and ERP (more than 10 hours per patient) or an SSRI. Clomipramine may also be used as an alternative to an SSRI.
Severe functional impairment
Those with severe functional impairment should be offered high-intensity psychological therapy plus an SSRI.
Evidence comparing treatment options
- Cochrane reviews have determined psychological therapies to be effective in OCD, although have not been able to recommend one specific technique. Likewise, SSRIs have been shown to have efficacy over placebo but no evidence supports one over another or shows superiority between SSRIs and psychological therapies.
- Studies show psychological therapies such as CBT delivered by phone or internet to be effective[9, 10].
- One randomised comparative trial concluded that group CBT was an effective treatment but did not exclude the possibility that individual therapy was superior.
- One study found that two prominent features of OCD - overestimations of danger and inflated beliefs of personal responsibility - benefited equally from CBT.
- Inference-based treatment (IBT) is a method of psychological treatment sometimes used as an adjunct to CBT in OCD patients with obsessional doubt.
- ERP is a technique in which patients are repeatedly exposed to the situation causing them anxiety (eg, exposure to dirt) and are prevented from performing repetitive actions, which lessens that anxiety (eg, washing their hands). Efficacy has been demonstrated in studies[14, 15]. This method is only used after extensive counselling and discussion with the patient who knows fully what to expect. After an initial increase in anxiety, the level gradually decreases. The patient feels that they have confronted their worst fears without anything terrible happening. One study found that, providing there was adherence to a standardised treatment manual, the experience (or inexperience) of the therapist did not affect the outcome.
- Mild dysfunction : offer guided self-help along with support and information for the family or carers. If this fails, or if it is unavailable locally, refer to Children and Adolescents Mental Health Services (CAMHS).
- Moderate-to-severe: refer to CAMHS. Psychological therapy will be with CBT/ERP as for adults but should involve family/carers. It may be individual or group therapy, depending on the preference of the patient. CBT has been shown to be effective in children for OCD and other associated disorders[16, 17]. Furthermore, CBT may be more effective than SSRI treatment.
- If psychological treatment fails, factors which might require other interventions may be involved - eg, co-existence of comorbid conditions, learning disorders, persisting psychosocial risk factors such as family discord, presence of parental mental health problems.
- Pharmacotherapy: in children over the age of 8, adding an SSRI might be appropriate, following a multidisciplinary review. In children under the age of 18, an SSRI should only be prescribed after assessment by a specialist psychiatrist for this age group (but see below concerning safety issues).
Using selective serotonin reuptake inhibitors
See also the separate Selective Serotonin Reuptake Inhibitors article.
SSRIs in adults
- There is a range of potential side-effects (see individual drugs), including worsening anxiety, suicidal thoughts and self-harm, which need to be carefully monitored, especially in the first few weeks of treatment. Caution is advised in view of increased risk of suicidal thoughts and self-harm in people with depression.
- In high-risk patients, prescribe limited quantities, keep in contact especially during the first few weeks and actively monitor for akathisia (restlessness and the urge to move), suicidal ideation, agitation and increased anxiety.
- NICE recommends fluoxetine, fluvoxamine, paroxetine, sertraline or citalopram. There are no significant differences in efficacy.
- There is commonly a delay in onset of up to 12 weeks, although depressive symptoms improve more quickly.
- When prescribing, provide written supporting material.
- If there is no response to a standard dose, check compliance, check interaction with drugs and alcohol, then consider titrating to a maximum dose according to the Product Characteristics.
- Monitor all patients around the time of dosage changes.
- Continue for at least twelve months from remission and withdraw gradually.
- There is a risk of discontinuation/withdrawal symptoms on stopping the drug, missing doses, or reducing the dose.
- Clomipramine may be used as an alternative if the person is intolerant of SSRIs, if at least one SSRI has been ineffective, or if they have previously responded successfully to clomipramine.
SSRIs in children and young people (8-18 years)
- Caution is advised, as there is a risk of self-harm or suicide in patients with depression. Only prescribed by specialists, in conjunction with psychological therapy following assessment by a child and adolescent psychiatrist who should also be involved in dosage changes and discontinuation.
- Sertraline and fluvoxamine are the only SSRIs licensed for this use, unless significant co-existing depression is evident, in which case fluoxetine should be used.
- Discuss adverse effects, dosage, monitoring, etc with the patient/family/carers, as per adults (see above).
- SSRIs should only be prescribed in conjunction with CBT.
The following are in conjunction with specialist assessment and multidisciplinary review:
- Try another SSRI.
- Consider change to clomipramine; however, there is a greater tendency to produce adverse effects. Do baseline ECG and check BP. Start with a small dose, titrate according to response and monitor regularly.
- Antipsychotics are sometimes used to augment the effect of an SSRI. There is evidence for haloperidol, risperidone and aripiprazole.
- Intensive inpatient therapy or residential/supportive care may occasionally be needed for people with chronic severe dysfunction.
- Neurosurgery may be considered for severely ill patients who do not respond to CBT and medication. Risks, benefits, long-term postoperative management and patient selection should all be carefully considered before embarking on treatment. Patient selection can be improved by the use of neuroimaging. Anterior capsulotomy is the traditional procedure.
- Deep brain stimulation is currently being explored and has shown promise.
4th September 2020
Transcranial Magnetic Stimulation (TMS)
- The National Institute for Health and Care Excellence (NICE) has published technical guidance on the use of transcranial magnetic stimulation (TMS) in the treatment of OCD.
- TMS involves applying electromagnetic pulses to parts of the brain, with the objective of reducing the symptoms of OCD. The pulses stimulate the neurons to produce small electrical currents. The patient is awake throughout the procedure, which involves placing electromagnetic coils over specific areas of the head. Various methods are used targeting different areas of the brain and using low or high frequencies.
- Usually, treatment consists of daily sessions lasting approximately 30 minutes, for a few weeks.
- Repetitive TMS (rTMS) involves titrating the intensity of stimulation against the minimum intensity needed to elicit a motor response when the motor cortex is stimulated. This can be done by directly observing the movement of a body part such as the hand, or by electomyography.
- Conventional rTMS delivers repeated individual pulses at pre-set intervals (train of pulses). In theta-burst rTMS, pulses are repeatedly delivered in short bursts (train of bursts).
- NICE recommends that because the evidence for the efficacy of TMS is inadequate in quantity and quality, it should only be used in the context of research. This research should ideally be in the form of adequately powered, pre-registered controlled trials.
Further reading and references
Obsessive-compulsive disorder; NICE CKS, July 2013 (UK access only)
Veale D, Roberts A; Obsessive-compulsive disorder. BMJ. 2014 Apr 7348:g2183. doi: 10.1136/bmj.g2183.
Pauls DL; The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci. 201012(2):149-63.
The ICD-10 Classification of Mental and Behavioural Disorders; World Health Organization
Obsessive Compulsive Disorder - core interventions in the treatment of obsessive compulsive disorder and body dysmorphic disorder; NICE Clinical Guideline (November 2005)
Abramowitz JS, Baucom D, Wheaton M, et al; Enhancing Exposure and Response Prevention for OCD: A Couple-Based Approach. Behav Modif. 2012 May 22.
Gava I, Barbui C, Aguglia E, et al; Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2007 Apr 18(2):CD005333.
Soomro GM, Altman D, Rajagopal S, et al; Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008 Jan 23(1):CD001765. doi: 10.1002/14651858.CD001765.pub3.
Herbst N, Voderholzer U, Stelzer N, et al; The potential of telemental health applications for obsessive-compulsive disorder. Clin Psychol Rev. 2012 May 2632(6):454-466.
Muller I, Yardley L; Telephone-delivered cognitive behavioural therapy: a systematic review and meta-analysis. J Telemed Telecare. 2011 Feb 28.
Jonsson H, Hougaard E, Bennedsen BE; Randomized comparative study of group versus individual cognitive behavioural therapy for obsessive compulsive behaviour. Acta Psychiatr Scand. 2010 Oct 12. doi: 10.1111/j.1600-0447.2010.01613.x.
Vos SP, Huibers MJ, Arntz A; Experimental investigation of targeting responsibility versus danger in cognitive therapy of obsessive-compulsive disorder. Depress Anxiety. 2012 Jul29(7):629-37. doi: 10.1002/da.21915. Epub 2012 Mar 23.
Aardema F, O'Connor K; Dissolving the tenacity of obsessional doubt: implications for treatment outcome J Behav Ther Exp Psychiatry. 2012 Jun
Seibell PJ, Hollander E; Management of obsessive-compulsive disorder. F1000Prime Rep. 2014 Aug 16:68. doi: 10.12703/P6-68. eCollection 2014.
Olatunji BO, Davis ML, Powers MB, et al; Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013 Jan47(1):33-41. doi: 10.1016/j.jpsychires.2012.08.020. Epub 2012 Sep 20.
O'Kearney RT, Anstey KJ, von Sanden C; Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev. 2006 Oct 18(4):CD004856.
James AC, James G, Cowdrey FA, et al; Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2015 Feb 182:CD004690. doi: 10.1002/14651858.CD004690.pub4.
Ivarsson T, Skarphedinsson G, Kornor H, et al; The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Psychiatry Res. 2015 May 30227(1):93-103. doi: 10.1016/j.psychres.2015.01.015. Epub 2015 Jan 28.
Rodman AM, Milad MR, Deckersbach T, et al; Neuroimaging contributions to novel surgical treatments for intractable obsessive-compulsive disorder Expert Rev Neurother. 2012 Feb
Pepper J, Hariz M, Zrinzo L; Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. J Neurosurg. 2015 May122(5):1028-37. doi: 10.3171/2014.11.JNS132618. Epub 2015 Jan 30.
Transcranial magnetic stimulation for obsessive-compulsive disorder; NICE Interventional procedures guidance, August 2020